Serum Institute OF India Private Limited — Vaccine Exporter Profile
Indian Pharmaceutical Exporter · #1 for Vaccine · $161.3M export value · DGFT Verified
Serum Institute OF India Private Limited is the #1 Indian exporter of Vaccine with $161.3M in export value and 3,225 verified shipments. Serum Institute OF India Private Limited holds a 15.5% market share in Vaccine exports across 164 countries. The company exports 2 pharmaceutical products worth $162.2M across 1 therapeutic categories.
Serum Institute OF India Private Limited — Vaccine Export Profile: Buyers & Destinations
Where Does Serum Institute OF India Private Limited Export Vaccine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| TURKEY | $4.9M | 136 | 7.3% |
| PHILIPPINES | $4.2M | 146 | 6.2% |
| NIGERIA | $2.5M | 62 | 3.7% |
| EGYPT | $2.1M | 83 | 3.1% |
| MEXICO | $1.8M | 71 | 2.7% |
| THAILAND | $1.6M | 93 | 2.4% |
| PAKISTAN | $1.6M | 48 | 2.4% |
| PERU | $1.5M | 65 | 2.3% |
| KENYA | $1.4M | 122 | 2.1% |
| SYRIA | $1.3M | 35 | 1.9% |
Serum Institute OF India Private Limited exports Vaccine to 185 countries. The largest destination is TURKEY accounting for 7.3% of Serum Institute OF India Private Limited's Vaccine shipments, followed by PHILIPPINES (6.2%) and NIGERIA (3.7%). These destinations reflect Serum Institute OF India Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Vaccine from Serum Institute OF India Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| UNICEF SUPPLY DIVISION | CONGO | $4.2M | 99 |
| XXICEXXSUPXXY DXXISIXX | AFGHANISTAN | $1.9M | 48 |
| GENPHARM INC | PHILIPPINES | $1.6M | 59 |
| TO THE ORDER OF TMBTHANACHART BANK | THAILAND | $1.5M | 83 |
| NATIONAL PRIMARY HEALTH CARE | NIGERIA | $1.4M | 30 |
| SERUM INSTITUTE INC | GUATEMALA | $1.2M | 57 |
| SERUM LIFE SCIENCES LTD | IRELAND | $1.2M | 27 |
| BIRMEX - LABORATORIOS DE BIOLOGICOS | MEXICO | $1.1M | 35 |
| XXRUMXXIFEXXCIEXXES XXD | SUDAN | $1.1M | 24 |
| SERUM LIFE SCIENCES LIMITED | SUDAN | $1.1M | 24 |
Serum Institute OF India Private Limited supplies Vaccine to 668 buyers globally. The largest buyer is UNICEF SUPPLY DIVISION (CONGO), followed by XXICEXXSUPXXY DXXISIXX (AFGHANISTAN) and GENPHARM INC (PHILIPPINES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Vaccine Export Value and How Much Does Serum Institute OF India Private Limited Contribute?
India exported $313.3M worth of Vaccine through 14,355 shipments from 325 suppliers to 192 countries, serving 2,202 buyers globally. Serum Institute OF India Private Limited contributes $161.3M to this total, accounting for 15.5% of India's Vaccine exports. Serum Institute OF India Private Limited ships Vaccine to 185 countries through 668 buyers.
What Is the Average Shipment Value for Serum Institute OF India Private Limited's Vaccine Exports?
Serum Institute OF India Private Limited's average Vaccine shipment value is $50.0K per consignment, based on 3,225 shipments totaling $161.3M. The largest destination is TURKEY (7.3% of Serum Institute OF India Private Limited's Vaccine exports).
How Does Serum Institute OF India Private Limited Compare to Other Indian Vaccine Exporters?
Serum Institute OF India Private Limited ranks #1 among 325 Indian Vaccine exporters with a 15.5% market share. The top 3 exporters are SERUM INSTITUTE OF INDIA PRIVATE LIMITED ($161.3M), BIOLOGICAL E. LIMITED ($43.0M), BHARAT BIOTECH INTERNATIONAL LIMITED ($30.4M). Serum Institute OF India Private Limited processed 3,225 shipments to 164 destination countries.
What Vaccine Formulations Does Serum Institute OF India Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| [SINGLE VACCINES FOR HEPATITIS] HEPATITI | $3.3M | 149 |
| MIXED VACCINE FOR MMR-VIRAL VACCINE- | $2.5M | 68 |
| VACCINE FOR HUMAN MEDICINE- | $2.4M | 70 |
| OTHER MIX VACCINE-LIQUID VACCINE- | $2.2M | 61 |
| [MIXED VACCINES FOR DIPHTHERIA AND TETAN | $2.0M | 69 |
| SINGLE VACCINES FOR TB- | $1.4M | 49 |
| VACCINE FOR HUMAN MEDICINE [SINGLE VACCI | $1.4M | 50 |
| (SINGLE VACCINES FOR HEPATITIS) HEPATITI | $1.4M | 90 |
| VACCINE FOR HUMAN MEDICINE (SINGLE VACCI | $1.3M | 44 |
| OTHER SINGLE VACCINE-VIRAL VACCINE- | $1.3M | 30 |
Serum Institute OF India Private Limited exports 1016 distinct Vaccine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is [SINGLE VACCINES FOR HEPATITIS] HEPATITI with 149 shipments worth $3.3M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Vaccine to Key Markets
What Serum Institute OF India Private Limited must comply with to export Vaccine to its top destination countries
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Serum Institute OF India Private Limited Compare to Nearest Vaccine Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | SERUM INSTITUTE OF INDIA PRIVATE LIMITED ★ | $161.3M | 3,225 | 164 | $50.0K |
| 2 | BIOLOGICAL E. LIMITED | $43.0M | 859 | 104 | $50.0K |
| 3 | BHARAT BIOTECH INTERNATIONAL LIMITED | $30.4M | 609 | 77 | $50.0K |
Serum Institute OF India Private Limited ranks #1 among 325 Indian Vaccine exporters. Average shipment value of $50.0K compared to the market average of $964.0K. The closest competitors by value are BIOLOGICAL E. LIMITED and BHARAT BIOTECH INTERNATIONAL LIMITED.
Which Indian Ports Ship Vaccine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 3,489 | 24.3% |
| SAHAR AIR | 2,995 | 20.9% |
| Bombay Air | 855 | 6.0% |
| HYDERABAD ACC (INHYD4) | 839 | 5.8% |
| HYDERABAD AIR | 805 | 5.6% |
| DELHI AIR CARGO ACC (INDEL4) | 752 | 5.2% |
| DELHI AIR | 581 | 4.0% |
| AHEMDABAD AIR ACC (INAMD4) | 373 | 2.6% |
What Other Other Products Does Serum Institute OF India Private Limited Export?
Serum Institute OF India Private Limited also exports these other products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Serum Institute OF India Private Limited's Vaccine Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like SII. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight charges and extended transit times. These disruptions have significantly impacted pharmaceutical exports to the Middle East, with potential losses estimated between ₹2,500 crore to ₹5,000 crore in March 2026. (fortuneindia.com) Such logistical challenges are particularly concerning for time-sensitive products like vaccines, where cold-chain integrity is paramount.
Conversely, the US-China trade tensions have created opportunities for Indian pharmaceutical companies. The imposition of tariffs on Chinese goods has led US importers to seek alternative suppliers, benefiting Indian exporters. However, the recent US tariffs on imports from multiple countries, including India, have introduced new complexities. These tariffs, reaching up to 39%, could affect nearly 55% of India's exports to the US, posing a significant challenge for companies like SII that rely on the American market. (apnews.com)
In the European Union, regulatory changes such as the Falsified Medicines Directive (FMD) have imposed stringent serialization and traceability requirements. Compliance with these regulations necessitates substantial investment in infrastructure and quality control systems. For SII, ensuring adherence to these evolving standards is crucial to maintaining access to the lucrative EU market.
Serum Institute OF India Private Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the US FDA and WHO emphasizing Good Manufacturing Practices (GMP). India, hosting over 600 US FDA-approved manufacturing sites, faces ongoing challenges in maintaining compliance. In 2023, the US FDA conducted more than 200 inspections in India, underscoring the critical importance of quality assurance. (fact.net.in)
For SII, maintaining compliance with international quality standards is imperative. The company's proactive approach is evident in its collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI) in January 2024, aimed at enhancing rapid vaccine production capabilities. (outlookbusiness.com) Such partnerships not only bolster SII's regulatory standing but also reinforce its commitment to global health security.
About Serum Institute OF India Private Limited
Serum Institute OF India Private Limited exports 2 products worth $162.2M. Beyond Vaccine, top products include Antitoxin. View the complete Serum Institute OF India Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vaccine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Vaccine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Serum Institute OF India Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 3,225 individual customs records matching Serum Institute OF India Private Limited exporting Vaccine, covering 1016 formulations to 185 countries via 668 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 192+ countries, 2,202+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Vaccine Export Data from Serum Institute OF India Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Serum Institute OF India Private Limited's Vaccine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Serum Institute OF India Private Limited
Full Company Profile →
2 products · $162.2M total trade · 1 categories
Vaccine Stats
Company Overview
Top Products by Serum Institute OF India Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Serum Institute OF India Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vaccine. For current shipment-level data, contact TransData Nexus.